Aurovela 24 Fe

Aurobindo Pharma Limited🇺🇸 United States

FDA Page

Effective Date: Nov 21, 2023
Approval ID: 3eb092dc-2ec1-4d55-b1fe-69505608e04a
Products: 1 registered
Version: 14

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use AUROVELA 24 Fe safely and effectively. See Full Prescribing Information for AUROVELA 24 Fe. AUROVELA 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) for Oral Use Initial U.S. Approval: 1968

Quick Stats

Total Products1

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.